Shop

Showing 17–32 of 189 results

• 

  TENODX Tenofovir Alafenamide

  USD 13.00 Sold 2,300+
  Tenofovir alafenamide (TAF) is a nucleotide reverse transcriptase inhibitor and a prodr…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  TAZEDX Tazemetostat

  USD 624.00 Sold 1,100+
  TAZEMETOSTAT is a drug that targets a protein in cancer cells and stops them from growi…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  REPODX Repotrectinib

  USD 277.33 Sold 600+
  Repotrectinib is a next-generation tyrosine kinase inhibitor that targets the ROS1 and …
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  TOFADX Tofacitinib

  USD 13.00 Sold 700+
  Tofacitinib is a JAK inhibitor that effectively inhibits the activity of JAK1 and JAK3,…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  BESIDX Abemaciclib

  USD 242.67 Sold 1,000+
  Abemaciclib is a selective CDK4 and CDK6 inhibitor used to treat advanced or metastatic…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  KESODX Crizotinib

  USD 173.33 Sold 1,800+
  Crizotinib is an ALK and ROS1 inhibitor used to treat non-small cell lung cancer. Crizo…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  Mobocertinib Capsules (MOBODX) 40mg – Buy Online

  USD 329.33 Sold 2,000+
  The U.S. FDA has granted accelerated approval to mobotinib for the treatment of adult p…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  BARUDX Baricitinib

  USD 13.00 Sold 2,300+
  Baricitinib is a selective, reversible JAK1 and JAK2 inhibitor that is taken orally onc…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  AIVODX Ivosidenib 250mg

  USD 242.67 Sold 2,400+
  Ivosidenib is the world's first approved IDH1 inhibitor. In July 2018, Ivosidenib was a…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  ENTREDX Entrectinib 200mg

  USD 199.33 Sold 1,400+
  Entrectinib is an inhibitor of tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, T…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  WELIDX Belzutifan

  USD 849.33 Sold 800+
  Belzutifan is a HIF-2α inhibitor. HIF, or hypoxia-inducible factor, is a key oncogenic …
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  TUKADX Tucatinib 150mg

  USD 69.33 Sold 2,200+
  Tucatinib is a small-molecule oral tyrosine kinase inhibitor (TKI) that was approved fo…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  RUSODX Ruxolitinib 5mg

  USD 104.00 Sold 1,200+
  In November 2011, ruxolitinib tablets were first approved for marketing in the United S…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  ERDADX Erdafitinib 4mg

  USD 156.00 Sold 2,200+
  In March 2018, the U.S. Food and Drug Administration (FDA) granted erdatinib Breakthrou…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  SEPADX Selpercatinib 40mg

  USD 329.33 Sold 1,600+
  On May 8, 2020, the U.S. Food and Drug Administration (FDA) approved selpercatinib, the…
  Select options This product has multiple variants. The options may be chosen on the product page
• 

  LENVIDX Lenvatinib 10mg

  USD 78.00 Sold 800+
  Lenvatinib is a multi-target receptor tyrosine kinase (RTK) inhibitor that inhibits vas…
  Select options This product has multiple variants. The options may be chosen on the product page